Termination of Registration of a Class of Security Under Section 12(g) (15-12g)
February 06 2017 - 05:08PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
15
CERTIFICATION
AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO
FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission
File Number: 0-32201
|
BIO-MATRIX
SCIENTIFIC GROUP, INC.
|
(Exact
name of registrant as specified in its charter
|
|
4700
Spring Street, Suite 304, La Mesa, California, 91942
(619)
702-1404
|
|
|
(Address,
including zip code, and telephone number, including area code, of registrant’s principal executive offices)
|
|
Common
Stock, par value $0.0001 per share
|
|
(Title
of each class of securities covered by this Form)
|
|
None
|
(Title
of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
|
Please
place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file
reports:
Approximate
number of holders of record as of the certification or notice date:
455
Pursuant
to the requirements of the Securities Exchange Act of 1934, Bio Matrix Scientific Group Inc. has caused this
certification/notice to be signed on its behalf by the undersigned duly authorized person.
Date:
|
February 6, 2017
|
|
By:
|
/s/ Davis Koos
|
|
Name:
|
David Koos
|
|
Title:
|
Chief Executive Officer
|
|
|
|
|